Related Experiment Video
Updated: Jul 22, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Cerebral venous thrombosis in children
K S Carvalho1, J B Bodensteiner, P J Connolly
1Division of Pediatric Neurology, Indiana University School of Medicine, James Whitcomb Riley Hospital for Children, Indianapolis, USA.
Insights
Cerebral venous thrombosis (CVT) in children, especially neonates, is a significant cause of stroke. Early diagnosis and testing for coagulation disorders are crucial for better outcomes in pediatric CVT.
Area of Science:
- Pediatric Neurology
- Neuroradiology
- Hematology
Background:
- Cerebral venous thrombosis (CVT) is a critical cause of stroke in pediatric populations.
- Understanding the natural history of CVT is vital for developing effective interventions.
- Neonatal CVT may be more prevalent than previously recognized, with poorer prognoses.
Purpose of the Study:
- To analyze the risk factors, clinical presentation, radiographic findings, and neurological outcomes of pediatric cerebral venous thrombosis.
- To evaluate the incidence and impact of coagulopathies in children with CVT.
- To emphasize the importance of screening for coagulation disorders in all pediatric CVT cases.
Main Methods:
- Retrospective analysis of 31 children diagnosed with CVT via head CT or MRI.
- Review of patient data including risk factors, clinical symptoms, imaging results, and neurological outcomes.
- Coagulation status was assessed in a subset of patients.
Main Results:
- The median age was 14 days, with 61% being neonates. Common risk factors included mastoiditis, pulmonary hypertension, cardiac malformations, and dehydration.
- Seizures, fever, respiratory distress, and lethargy were the most frequent clinical features.
- At follow-up, 11 patients were normal, 13 had developmental delay, and 2 died. Protein C and antithrombin III deficiencies were common coagulopathies.
Conclusions:
- Pediatric cerebral venous thrombosis, particularly in neonates, presents unique challenges and poorer outcomes.
- Coagulation disorders are prevalent in children with CVT and warrant thorough investigation.
- Testing for coagulation disorders should be a standard part of managing pediatric CVT.
Abstract:
Cerebral venous thrombosis is an important cause of stroke in children. Understanding the natural history of the disease is essential for rational application of new interventions. We retrospectively identified 31 children with cerebral venous thrombosis confirmed by head computed tomography (4 patients) or by magnetic resonance imaging (27 patients). Risk factors, clinical and radiographic features, and neurologic outcomes were analyzed. There were 21 males and 10 females aged 1 day to 13 years (median 14 days). Nineteen (61%) were neonates. The most common risk factors included mastoiditis, persistent pulmonary hypertension, cardiac malformation, and dehydration. The chief clinical features were seizures, fever, respiratory distress, and lethargy. Fifteen patients had infarctions (8 hemorrhagic, 7 ischemic). Protein C and antithrombin III deficiency were the most common coagulopathies among 14 tested patients. On discharge, 11 patients were normal, 17 had residual deficits, and 2 patients died. Twenty-seven patients were followed from 1 month to 12 years (mean 22 months). At follow-up, 11 patients were normal, and 13 patients had development delay. One had residual hemiparesis and cortical visual impairment. Two had other deficits. Neonatal cerebral venous thrombosis is probably more common than previously thought, and outcomes are worse in this group. All children with cerebral venous thrombosis should be tested for coagulation disorders.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Hemorrhagic Stroke ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Cerebral Edema ll: Pathophysiology

